Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
2 All-Weather Stocks to Buy Without Hesitation Right Now
08:45am, Friday, 31'st Mar 2023
While high inflation is pressuring the market, many healthcare businesses remain resilient. DexCom has a long runway for growth as the need for diabetes treatment expands.
Investment in procedural medical devices is safer for valuation, says E Squared's Les Funtleyder
02:12pm, Thursday, 30'th Mar 2023
Les Funtleyder, portfolio manager for E Squared Capital Management, joins 'The Exchange' to discuss big cap pharma's Q1 performance, the dollar weakness contributing to biotech gains, and investment o
Where Will DexCom Be in 1 Year?
07:45am, Wednesday, 29'th Mar 2023
DexCom plans to keep rolling out key new devices in the next year. The company should continue growing its revenue and installed base.
11 stocks in the S&P 500 expected to form an exclusive growth club for investors
08:10am, Monday, 27'th Mar 2023
Following an 18% decline for the S&P 500 index (with dividends reinvested) in 2022 and a volatile and disappointing pullback from this year's stock-market rebound that crested early in February, some
Nasdaq Bear Market: 2 Growth Stocks to Buy That Keep Bucking the Trend
05:41am, Saturday, 25'th Mar 2023
The Nasdaq Composite index has been down for over a year now, but some of its components are soaring. Vertex Pharmaceuticals is the only drugmaker selling lifesaving treatments for patients who inheri
Dexcom (DXCM) Launches G6 Glucose Monitoring System in Canada
01:45pm, Friday, 24'th Mar 2023
Dexcom (DXCM) announces the availability of standard of care in diabetes management - G6 CGM system - for type 1 and 2 patients with basal and bolus insulin or using an insulin pump in Canada.
Dexcom Stock Option Trade Could Return $465 While Risking Just $35
12:10pm, Friday, 24'th Mar 2023
Still caught in a wide performance range, it is beginning to show signs of price improvement. The post Dexcom Stock Option Trade Could Return $465 While Risking Just $35 appeared first on Investor's B
DexCom: Riding The Growth Wave
06:32pm, Wednesday, 15'th Mar 2023
DexCom has built itself an impressive market position against large competitors in the diabetes space. Future growth should remain relatively easy as reimbursed populations continue to grow, and the o
Silicon Valley Bank signed exclusive banking deals with some clients, leaving them unable to diversify
08:21pm, Sunday, 12'th Mar 2023
Silicon Valley Bank required some clients to agree to exclusivity clauses, disabling them from diversifying where they held their money, SEC records show.
Stock Market Cedes Early Gains Ahead Of Powell Testimony; MercadoLibre Clears New Entry, But Dexcom Plunges
05:45pm, Monday, 06'th Mar 2023
The stock market ended mildly mixed Monday, but early gains faded and small-cap stocks lagged badly. MercadoLibre cleared a new entry.
Dexcom Pummeled On A New FDA Clearance For Key Rival Abbott Laboratories
12:18pm, Monday, 06'th Mar 2023
Dexcom stock toppled Monday after the FDA cleared Abbott Laboratories to pair its body-worn glucose monitors with automated insulin pumps. The post Dexcom Pummeled On A New FDA Clearance For Key Rival
Dexcom Nears Breakout On A Surprise Medicare Decision For Its Devices
02:04pm, Thursday, 02'nd Mar 2023
Dexcom stock popped Thursday after CMS said it would cover continuous glucose monitors for a broader group of type 2 diabetics. The post Dexcom Nears Breakout On A Surprise Medicare Decision For Its D
Where to Invest $1,000 in a 2023 Nasdaq Bear Market
05:05am, Thursday, 02'nd Mar 2023
Even a modest investment in great companies can pay off over the long run.
Should Abbott and DexCom Investors Be Worried About Apple's Latest News?
05:52am, Tuesday, 28'th Feb 2023
The continuous glucose monitoring market could heat up.
Better Buy: Abbott Laboratories or DexCom Stock?
09:45am, Friday, 24'th Feb 2023
Both stocks should benefit from the growth in diabetes care.
